x 

0 Activities
0 Activities
    • No Saved Activities
Results 1 - 59 of 59
9630-ild
Improving the Diagnosis and Management of PPF: Rapid Recap
9630-ild
Improving the Diagnosis and Management of PPF: A Focus on SSc-ILD and IPF
9360-0001_263x149
Improving the Management of Patients with PPF - Slide Library
MicrosoftTeams-image (18)
Coordinating Care for Patients With Progressive Pulmonary Fibrosis - Rapid Recap
MicrosoftTeams-image (18)
Coordinating Care for Patients With Progressive Pulmonary Fibrosis - Slide Deck
MicrosoftTeams-image (18)
Coordinating Care for Patients With Progressive Pulmonary Fibrosis
9260-child
Providing a Medical Home for Kids with Rare Lung Disease
9193-case3
SSc-ILD With Rapid Progression
9193-case2
Delayed Diagnosis of SSc-ILD with PPF
9193-case1
Identifying the Signs and Symptoms of PPF
Am I Treating My Patients With Psoriatic Disease Effectively?
Am I Treating My Patients with Psoriatic Disease Effectively?
9088-sscild-slides
Practical Solutions to SSc-ILD Treatment - Slide Deck
No image set
Practical Solutions to SSc-ILD Treatment
No image set
SSc-ILD Individualized Treatment
No image set
Fundamentals of Diagnosis: SSc-ILD
No image set
Rheumatic Learning: Next Steps for Mr. S's Established RA
No image set
Rheumatic Learning: Next Steps for Mrs. J's Early RA
No image set
Rheumatic Learning: How Can You Help Jeff With His Psoriatic Arthritis?
No image set
Rheumatic Learning: How can you help Andrea with her Psoriatic Arthritis?
No image set
Practical Applications From What We Heard at Virtual ACR
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
New Directions in the Diagnosis of RA ILD
No image set
Therapies on the Horizon for RA ILD
No image set
New Treatment Options for SSc ILD
No image set
Updates on Current Treatment Options for RA ILD
No image set
Biochemical Profiles of Radiographic Patterns in SSc-ILD
No image set
Factors Associated with Disease Progression in the SENSCIS Trial
No image set
Machine Learning Assisted Prediction of Progression in SSc-ILD
No image set
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
No image set
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
No image set
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
No image set
Updates on Current Treatment Options for RA-ILD
cc4
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
The SLE Consult: Diagnosis, Treatment Selection, Treatment Targets, and Monitoring
No image set
The SLE Consult: Lupus Nephritis, Patient-Clinician Communication, and Treatment Adherence
No image set
The Essential Role of Primary Care in SLE
No image set
A Step-by-Step Guide to Diagnosing SLE in the Primary Care Setting
9907-0006_shared
Engage Your Patients in Shared Decision-Making
9907-0005_cardio
Is It IPF or Cardiovascular Disease?
9907-0004_ip
Interstitial Pneumonia with Autoimmune Features
9907-0003_pf-ild
How to Identify Progressive Fibrosing ILD
9907-0002_ctd
When Is It a Connective Tissue Disease?
biosims-archmed icon2
Top Questions about Biosimilars in Rheumatology
IL-rheum-case3
Considering Biosimilars in Patients Failing their Initial Biologic
IL-rheum-case2
When to Switch? Biologically Experienced Patients with Spondyloarthritis
IL-rheum-case1
Innovator or Biosimilar for a Patient with Rheumatoid Arthritis
IL-fund-case4
Interchangeability and Pharmacy-Level Substitution
IL-fund-case3
FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
IL-fund-case2
What is the Difference Between a Biosimilar and a Generic?
IL-fund-case1
What is a Biologic?
biosims-full
Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics
biosims-full3
Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?
biosims-green3
Pharmacovigilance and Biosimilars: Any Special Considerations?
biosims-full5
Interchangeability and Biosimilars: What will this Mean for Clinical Practice?
biosims-green8
Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?
biosims-full7
Biosimilars: As Safe and Effective as the Reference Product?
biosims-green
Drift and the Manufacturing of Biologics: What is it and Does it Matter?
biosims-full8
Biosimilars in Clinical Practice: Interchangeability and Extrapolation

Search